Benefit of a second opinion for lung cancer: no recurrent disease, but infection

J Thorac Oncol. 2012 Aug;7(8):e6-7. doi: 10.1097/JTO.0b013e31825cca93.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Carcinoma, Non-Small-Cell Lung / microbiology
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Ciprofloxacin / therapeutic use
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Cranial Irradiation
  • Etoposide / administration & dosage
  • Female
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Humans
  • Lung Neoplasms / microbiology
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Middle Aged
  • Neoplasm Recurrence, Local*
  • Pemetrexed
  • Postoperative Care
  • Prognosis
  • Referral and Consultation / statistics & numerical data*

Substances

  • Anti-Infective Agents
  • Glutamates
  • Pemetrexed
  • Ciprofloxacin
  • Guanine
  • Etoposide
  • Cisplatin